Ocugen Inc, a pioneering biotechnology leader in gene therapies for blindness diseases, announced that the first patient has been dosed in its phase 2/3 GARDian3 clinical trial for OCU410ST - a ...

SAGINAW COUNTY, Mich. (WJRT) - An 82-year-old man who crashed into a Michigan State Police vehicle, resulting in the death of Trooper Joel Popp, has been sentenced to probation.

AP EAMCET Counselling 2025 Highlights: APSCHE has released the allotment result for the first phase of AP EAMCET 2025. Candidates are advised to visit — eapcet-sche.aptonline.in — to check ...

News GlobeNewswire Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody® iSCIB1+ ...

I have early Alzheimer’s and my husband has stage 4 kidney disease. We just inherited $50K. How can this help us? ‘The Voice' Sets Adam Levine, John Legend and Kelly Clarkson as Season 29 ...

PUTRAJAYA, July 21 (Bernama) -- The Ministry of Energy Transition and Water Transformation (PETRA) announced that Phase 2 of the Sungai Kelantan Integrated River Basin Development Project (PLSB) is ...

Based on these positive Phase 2 results, Cloudbreak Pharma Inc. plans to advance CBT-004 into Phase 3 development and initiate discussions with the U.S. Food and Drug Administration (FDA) to ...

Preliminary results from the TRIFOUR trial highlight nadunolimab's potential in treating advanced triple-negative breast cancer, showing promising efficacy and safety.

– Data Support Advancement of Alixorexton to Phase 3 Development in Narcolepsy – DUBLIN, July 21, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the ...

Therefore, a multicenter, single-arm, phase 2 study was conducted to investigate the efficacy and safety of de-escalated neoadjuvant chemotherapy regimen of pyrotinib, trastuzumab and nab-paclitaxel ...

Patients with COPD and type 2 inflammation who were given dupilumab showed reduced type 2 inflammatory biomarkers, with elevated blood eosinophil count and FeNO predicting greater treatment response.